A Web-Based Prostate Cancer-Specific Holistic Needs Assessment (CHAT-P): Multimethod Study From Concept to Clinical Practice.

Autor:	Nanton V; Warwick Medical School, University of Warwick, Coventry, United Kingdom., Appleton R; Mental Health Policy Research Unit, Division of Psychiatry, University College London, London, United Kingdom., Ahmed N; Medical School, University of Sheffield, Sheffield, United Kingdom., Loew J; Lucerne School of Business, Lucerne, Switzerland., Roscoe J; Warwick Medical School, University of Warwick, Coventry, United Kingdom., Muthuswamy R; Prostate Cancer UK, London, United Kingdom., Patel P; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Dale J; Warwick Medical School, University of Warwick, Coventry, United Kingdom., Ahmedzai SH; Medical School, University of Sheffield, Sheffield, United Kingdom.
Jazyk:	angličtina
Zdroj:	JMIR cancer [JMIR Cancer] 2022 Oct 19; Vol. 8 (4), pp. e32153. Date of Electronic Publication: 2022 Oct 19.
DOI:	10.2196/32153
Abstrakt:	Background: Men with prostate cancer experience immediate and long-term consequences of the disease and its treatment. They require both long-term monitoring for recurrence or progression and follow-up to identify and help manage psychosocial and physical impacts. Holistic Needs Assessment aims to ensure patient-centered continuing cancer care. However, paper-based generic tools have had limited uptake within cancer services, and there is little evidence of their impact. With the expansion of remote methods of care delivery and to enhance the value of generic tools, we developed a web-based Composite Holistic Needs Assessment Adaptive Tool-Prostate (CHAT-P) specifically for prostate cancer. Objective: This paper described the context, conceptual underpinning, and approach to design that informed the development of CHAT-P, starting from the initial concept to readiness for deployment. Through this narrative, we sought to contribute to the expanding body of knowledge regarding the coproduction process of innovative digital systems with potential for enhanced cancer care delivery. Methods: The development of CHAT-P was guided by the principles of coproduction. Men with prostate cancer and health care professionals contributed to each stage of the process. Testing was conducted iteratively over a 5-year period. An initial rapid review of patient-reported outcome measures identified candidate items for inclusion. These items were categorized and allocated to overarching domains. After the first round of user testing, further items were added, improvements were made to the adaptive branching system, and response categories were refined. A functioning version of CHAT-P was tested with 16 patients recruited from 3 outpatient clinics, with interviewers adopting the think-aloud technique. Interview transcripts were analyzed using a framework approach. Interviews and informal discussions with health care professionals informed the development of a linked care plan and clinician-facing platform, which were incorporated into a separate feasibility study of digitally enhanced integrated cancer care. Results: The findings from the interview study demonstrated the usability, acceptability, and potential value of CHAT-P. Men recognized the benefits of a personalized approach and the importance of a holistic understanding of their needs. Preparation for the consultation by the completion of CHAT-P was also recognized as empowering. The possible limitations identified were related to the importance of care teams responding to the issues selected in the assessment. The subsequent feasibility study highlighted the need for attention to men's psychological concerns and demonstrated the ability of CHAT-P to capture red flag symptoms requiring urgent investigation. Conclusions: CHAT-P offers an innovative means by which men can communicate their concerns to their health care teams before a physical or remote consultation. There is now a need for a full evaluation of the implementation process and outcomes where CHAT-P is introduced into the clinical pathway. There is also scope for adapting the CHAT-P model to other cancers. (©Rebecca Appleton, Veronica Nanton, Nisar Ahmed, Joelle Loew, Julia Roscoe, Radha Muthuswamy, Prashant Patel, Jeremy Dale, Sam H Ahmedzai. Originally published in JMIR Cancer (https://cancer.jmir.org), 19.10.2022.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu